Thrombophilia and adverse pregnancy outcome

Robertson, L., Wu, O. and Greer, I. (2004) Thrombophilia and adverse pregnancy outcome. Current Opinion in Obstetrics and Gynecology, 16(6), pp. 453-458.

Full text not currently available from Enlighten.

Publisher's URL: http://journals.lww.com/co-obgyn/Abstract/2004/12000/Thrombophilia_and_adverse_pregnancy_outcome.3.aspx

Abstract

Purpose of review: Recent case-control studies and metaanalyses have attempted to quantify the risks associated with individual thrombophilic defects and adverse clinical events in pregnancy, including fetal loss, preeclampsia, placental abruption and intrauterine growth restriction. This review has examined the evidence. Recent findings: The literature is in general agreement that thrombophilia increases the risk of venous thromboembolism and adverse pregnancy outcomes, including pregnancy loss, preeclampsia, placental abruption and intrauterine growth restriction in pregnancy. However, the size of the estimated risks varies between individual studies due to heterogeneity in study design. Low-molecular-weight heparin has been shown to be the superior choice, on the grounds of safety and effectiveness, in preventing venous thromboembolism and improving pregnancy loss. Large-scale, randomized controlled studies are required, however, to confirm these findings. Although selective thrombophilia screening based on prior venous thromboembolism history has been shown to be marginally more cost-effective than universal screening in pregnancy, the overall clinical and economic benefit of universal and selective screening is unsupported. Summary: Despite the growing evidence in the literature, there are still gaps in our knowledge of thrombophilia and pregnancy. In particular, accurate estimates are required of the risks of venous thromboembolism and adverse pregnancy outcomes associated with some thrombophilias and the relative clinical and cost-effectiveness of different anticoagulation therapies in the prevention of venous thromboembolism and pregnancy loss. More large-scale studies are required to better inform clinicians and help determine optimum management and prevention strategies of thrombophilia and associated adverse clinical events in pregnancy.

Item Type:Articles
Keywords:thrombophilia, adverse pregnancy complications
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Greer, Prof Ian and Wu, Professor Olivia
Authors: Robertson, L., Wu, O., and Greer, I.
Subjects:R Medicine > RC Internal medicine
R Medicine > RG Gynecology and obstetrics
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Centre for Population and Health Sciences
Journal Name:Current Opinion in Obstetrics and Gynecology
Journal Abbr.:Curr. Opin. Obstet. Gyn.
ISSN:1040-872X
ISSN (Online):1473-656X

University Staff: Request a correction | Enlighten Editors: Update this record